IDPL, Gurgaon plant has been upgraded at the cost of Rs 3 crores as per ‘Revised Sch -M’ requirement and has obtained GMP certificate
The Union Minister of Chemicals & Fertilizers, Ananth Kumar, inaugurated the modernised general tablet section of IDPL, Gurgaon plant. The Minister of State for Chemicals & Fertilizers Hansraj Gangaram Ahir and Secretary, Department of Pharmaceuticals, Dr VK Subburaj were also present on the occasion. IDPL is one of the Central Public Sector Enterprises under the Department of Pharmaceuticals, engaged in manufacturing and marketing a large number of medicines for the masses.
According to a PIB release, General tablet section of IDPL, Gurgaon plant has been upgraded at the cost of Rs 3 crores as per ‘Revised Sch -M’ requirement and GMP certificate has been obtained. After modernisation, IDPL, Gurgaon plant will be able to launch new products in the field of diabetes, oncology, NSAIDS, Antibiotics-3rd Generation, nephrology and cardiology, as well as other segments of lifestyle diseases at affordable prices.
Kumar said that his department is working on the ‘Make-In-India’ mantra and this unit of IDPL is a step in that direction. He assured government’s full support in enhancing the efficiency and productivity of the public sector undertakings. Kumar said that providing affordable and good quality medicines to the masses of the country is important and the public sector undertakings have an important role to play as they are not driven by profit motives and serve public interest. He assured that the public sector undertakings will not be sold. Instead, a model will be developed for leveraging their assets to make them financially sustainable.
The minister said that a task force will be set up soon to look into all these aspects. He said that his ministry is working in close coordination with other concerned departments of the Government of India and the state governments as ‘Team India’ for attaining health security. The minister said that Jan Aushadhi will be revamped soon. He informed that pharma cluster, pharma parks and medical devices parks are also a step in this direction.
Ahir said that the government will provide support to IDPL in enhancing its production and its modernisation to enable it to regain its past glory.
Dr VK Subburaj said that besides affordability and availability, quality of the medicines is also important. He said the government is taking policy initiatives so that more and more Indian pharma companies become compliant to the WHO quality standards.
He also said that the drugs provided by IDPL and other public sector undertakings will facilitate in smooth functioning of the government’s programmes and help provide access to people of good quality medicines.
EP News Bureau – Mumbai